Green Cures Botanical Stock Performance
| GRCU Stock | USD 0.0001 0.0001 50.00% |
Green Cures holds a performance score of 14 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 7.31, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Green Cures will likely underperform. Use Green Cures Botanical jensen alpha and the relationship between the value at risk and day median price , to analyze future returns on Green Cures Botanical.
Risk-Adjusted Performance
14 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Green Cures Botanical are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Green Cures unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Price Earnings Ratio | 0.0002 |
Green |
Green Cures Relative Risk vs. Return Landscape
If you would invest 0.02 in Green Cures Botanical on August 24, 2024 and sell it today you would lose (0.01) from holding Green Cures Botanical or give up 50.0% of portfolio value over 90 days. Green Cures Botanical is currently generating 9.375% in daily expected returns and assumes 50.2967% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Green, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Green Cures Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Green Cures' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Green Cures Botanical, and traders can use it to determine the average amount a Green Cures' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1864
| Best Portfolio | Best Equity | GRCU | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 50.3 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Green Cures is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Green Cures by adding it to a well-diversified portfolio.
Green Cures Fundamentals Growth
Green Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Green Cures, and Green Cures fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Green Pink Sheet performance.
| Return On Equity | 0.55 | |||
| Return On Asset | 0.023 | |||
| Profit Margin | 4.96 % | |||
| Operating Margin | 0.62 % | |||
| Current Valuation | 4.85 M | |||
| Price To Sales | 2.80 X | |||
| Revenue | 13.17 K | |||
| EBITDA | 861.7 K | |||
| Cash And Equivalents | 80 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 3.1 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | (2.23) X | |||
| Cash Flow From Operations | (73.09 K) | |||
| Earnings Per Share | 3.15 X | |||
| Total Asset | 406 | |||
| Retained Earnings | (1.58 M) | |||
| Current Liabilities | 539 K | |||
About Green Cures Performance
Assessing Green Cures' fundamental ratios provides investors with valuable insights into Green Cures' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Green Cures is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Green Cures Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. Green Cures Botanical Distribution Inc. is based in Inglewood, California. Green Cures operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 20 people.Things to note about Green Cures Botanical performance evaluation
Checking the ongoing alerts about Green Cures for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Green Cures Botanical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Green Cures is way too risky over 90 days horizon | |
| Green Cures has some characteristics of a very speculative penny stock | |
| Green Cures appears to be risky and price may revert if volatility continues | |
| Green Cures has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 13.17 K. Net Loss for the year was (1.09 M) with profit before overhead, payroll, taxes, and interest of 989.6 K. | |
| Green Cures Botanical currently holds about 80 K in cash with (73.09 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Green Cures' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Green Cures' stock is overvalued or undervalued compared to its peers.
- Examining Green Cures' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Green Cures' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Green Cures' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Green Cures' pink sheet. These opinions can provide insight into Green Cures' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.